Our study firstly identified that lncRNA GAS6-AS1 and its related GAS6-AS1/YBX1/MYC axis contribute to poor prognosis of AML patients, and exert oncogenic roles in regulating cellular proliferation and tumor progression. The gene discussed is GAS6; the disease is acute myeloid leukemia.